Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.02 0.00 (-0.14%)
As of: Oct 22, 2026 · 9:53 AM EDT

Telomir Pharmaceuticals (TELO) Market Capitalization (2024 - 2026)

Updated

Telomir Pharmaceuticals' Market Capitalization came in at $88.03 million for Q2 2026, up 130.8% from $38.14 million a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) Market Capitalization (2024 - 2026) Analysis & Trends

For FY2025, Telomir Pharmaceuticals' Market Capitalization was $45.73 million, down 62.7% from FY2024.

  • Going back by year, Market Capitalization was $122.62 million in FY2024.
  • The Q2 2026 figure represents the highest quarterly Market Capitalization since Q1 2025.
  • Year-over-year, Market Capitalization increased in 1 of the last five quarters, with an average decline of 23.5%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,160.65 Bn 1,129.23 Bn 19.71 Bn
2 Johnson & Johnson 633.19 Bn 551.72 Bn 17.26 Bn
3 AbbVie 501.90 Bn 475.01 Bn 12.70 Bn
4 Merck 377.07 Bn 331.45 Bn 12.21 Bn
5 Novartis Ag 302.35 Bn 266.34 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 240.68 Bn 196.07 Bn 7.24 Bn
8 Gilead Sciences 193.20 Bn 167.40 Bn 6.22 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn
10 Telomir Pharmaceuticals 62.66 Mn 42.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 88.03 Mn
Dec 31, 2025 45.73 Mn
Sep 30, 2025 47.03 Mn
Jun 30, 2025 38.14 Mn
Mar 31, 2025 96.13 Mn
Dec 31, 2024 122.62 Mn
Sep 30, 2024 190.10 Mn
Jun 30, 2024 142.42 Mn
Mar 31, 2024 152.49 Mn
API Access

Telomir Pharmaceuticals Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=TELO&period=max&api_key=YOUR_API_KEY